{"id":"W4390107208","doi":"10.1002/ejhf.3118","title":"Natriuretic Peptides, Body Mass Index and Heart Failure Risk: Pooled Analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61","year":2023,"lang":"en","type":"article","venue":"European Journal of Heart Failure","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Esperion Therapeutics; HLS Therapeutics; Idorsia Pharmaceuticals; Daiichi Sankyo Europe; Servier; Assistance publique-Hôpitaux de Paris; Roche Diagnostics; Shionogi; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Zora Biosciences; Pfizer; Moderna; ARCA Biopharma; Medicines Company; Regado Biosciences; Belvoir Media Group; Novo Nordisk; MyoKardia; Allergan; AstraZeneca; Amarin Corporation; American Heart Association; Intarcia Therapeutics; Ironwood Pharmaceuticals, Incorporated; Brigham and Women's Hospital; Boston VA Research Institute; Boston Scientific Corporation; Cleveland Clinic; Bristol-Myers Squibb; Eli Lilly and Company; Abbott Laboratories; CSL Behring; Amgen; St. Jude Medical; Kowa Company; Abiomed; Sanofi; National Institutes of Health; Regeneron Pharmaceuticals","keywords":"Medicine; TIMI; Interquartile range; Internal medicine; Hazard ratio; Heart failure; Cardiology; Confidence interval; Body mass index; Natriuretic peptide; Percutaneous coronary intervention; Myocardial infarction","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01609923,0.0016522,0.008616044,0.001751512,0.0002091721,0.001876875,0.0009109193,0.001252858,0.002018201],"category_scores_gemma":[0.01289967,0.0008990942,0.01659063,0.001865362,0.0003921092,0.0009145256,0.001057579,0.0008753539,0.0003095908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003998606,"about_ca_system_score_gemma":0.0006087271,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001463799,"about_ca_topic_score_gemma":0.001923245,"domain_scores_codex":[0.9900919,0.006437574,0.001088569,0.001334326,0.0006782252,0.0003694252],"domain_scores_gemma":[0.9897051,0.005904565,0.002146731,0.001354356,0.0005575483,0.0003317065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1526889,0.0001879483,0.08757515,0.005423308,0.7340956,0.0001550882,0.0000752752,0.001768715,0.00223454,0.000151956,0.001510971,0.01413251],"study_design_scores_gemma":[0.01606582,0.007073352,0.2540545,0.0004198138,0.7137544,0.0001827324,0.0001079789,0.005030843,0.0009138133,0.0004765549,0.001809319,0.0001108165],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8654599,0.1180324,0.00489796,0.0004445799,0.0005756675,0.0003384569,0.00833233,0.0002263228,0.001692305],"genre_scores_gemma":[0.9897361,0.004690842,0.001387578,0.0002291947,0.0003066619,0.0003507297,0.002768672,0.00003556826,0.0004947136],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01609923,"threshold_uncertainty_score":0.0851419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02073132376587314,"score_gpt":0.2833603223327845,"score_spread":0.2626289985669113,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}